nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—SLC6A4—chronic obstructive pulmonary disease	0.136	0.312	CbGaD
Nortriptyline—CYP1A2—chronic obstructive pulmonary disease	0.124	0.284	CbGaD
Nortriptyline—HTR2A—chronic obstructive pulmonary disease	0.104	0.24	CbGaD
Nortriptyline—ALB—chronic obstructive pulmonary disease	0.0714	0.164	CbGaD
Nortriptyline—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.0621	0.155	CbGbCtD
Nortriptyline—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.0397	0.0992	CbGbCtD
Nortriptyline—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0345	0.0863	CbGbCtD
Nortriptyline—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0318	0.0796	CbGbCtD
Nortriptyline—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0268	0.067	CbGbCtD
Nortriptyline—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0232	0.0581	CbGbCtD
Nortriptyline—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0171	0.0428	CbGbCtD
Nortriptyline—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0171	0.0428	CbGbCtD
Nortriptyline—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0142	0.0356	CbGbCtD
Nortriptyline—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0142	0.0356	CbGbCtD
Nortriptyline—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0134	0.0336	CbGbCtD
Nortriptyline—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.013	0.0326	CbGbCtD
Nortriptyline—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.013	0.0326	CbGbCtD
Nortriptyline—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0116	0.029	CbGbCtD
Nortriptyline—ALB—Prednisone—chronic obstructive pulmonary disease	0.0111	0.0277	CbGbCtD
Nortriptyline—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0109	0.0273	CbGbCtD
Nortriptyline—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0108	0.027	CbGbCtD
Nortriptyline—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00738	0.0185	CbGbCtD
Nortriptyline—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00719	0.018	CbGbCtD
Nortriptyline—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00704	0.0176	CbGbCtD
Nortriptyline—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00627	0.0157	CbGbCtD
Nortriptyline—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00368	0.00921	CbGbCtD
Nortriptyline—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00358	0.305	CbGeAlD
Nortriptyline—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00347	0.00869	CbGbCtD
Nortriptyline—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.0013	0.111	CbGeAlD
Nortriptyline—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000414	0.0352	CbGeAlD
Nortriptyline—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000364	0.031	CbGeAlD
Nortriptyline—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000332	0.0282	CbGeAlD
Nortriptyline—CHRM1—trachea—chronic obstructive pulmonary disease	0.000304	0.0259	CbGeAlD
Nortriptyline—CHRM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000297	0.0253	CbGeAlD
Nortriptyline—Protriptyline—SLC6A4—chronic obstructive pulmonary disease	0.000282	0.0756	CrCbGaD
Nortriptyline—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.00028	0.0238	CbGeAlD
Nortriptyline—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.00027	0.023	CbGeAlD
Nortriptyline—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000262	0.0223	CbGeAlD
Nortriptyline—ORM1—lung—chronic obstructive pulmonary disease	0.000258	0.0219	CbGeAlD
Nortriptyline—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000252	0.0214	CbGeAlD
Nortriptyline—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.00265	CcSEcCtD
Nortriptyline—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000243	0.0206	CbGeAlD
Nortriptyline—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000242	0.00264	CcSEcCtD
Nortriptyline—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00264	CcSEcCtD
Nortriptyline—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000241	0.00263	CcSEcCtD
Nortriptyline—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000239	0.00261	CcSEcCtD
Nortriptyline—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000237	0.00259	CcSEcCtD
Nortriptyline—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00257	CcSEcCtD
Nortriptyline—Tension—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00257	CcSEcCtD
Nortriptyline—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00257	CcSEcCtD
Nortriptyline—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00257	CcSEcCtD
Nortriptyline—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00255	CcSEcCtD
Nortriptyline—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00255	CcSEcCtD
Nortriptyline—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000233	0.00254	CcSEcCtD
Nortriptyline—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00254	CcSEcCtD
Nortriptyline—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000231	0.0196	CbGeAlD
Nortriptyline—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00023	0.0025	CcSEcCtD
Nortriptyline—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000227	0.00248	CcSEcCtD
Nortriptyline—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00246	CcSEcCtD
Nortriptyline—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00246	CcSEcCtD
Nortriptyline—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000224	0.00244	CcSEcCtD
Nortriptyline—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00243	CcSEcCtD
Nortriptyline—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00243	CcSEcCtD
Nortriptyline—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00243	CcSEcCtD
Nortriptyline—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00242	CcSEcCtD
Nortriptyline—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00241	CcSEcCtD
Nortriptyline—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00241	CcSEcCtD
Nortriptyline—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00241	CcSEcCtD
Nortriptyline—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.0024	CcSEcCtD
Nortriptyline—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00022	0.0024	CcSEcCtD
Nortriptyline—SLC6A4—lung—chronic obstructive pulmonary disease	0.00022	0.0187	CbGeAlD
Nortriptyline—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000219	0.0186	CbGeAlD
Nortriptyline—CHRM1—lung—chronic obstructive pulmonary disease	0.000219	0.0186	CbGeAlD
Nortriptyline—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000219	0.00238	CcSEcCtD
Nortriptyline—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00236	CcSEcCtD
Nortriptyline—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00236	CcSEcCtD
Nortriptyline—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00236	CcSEcCtD
Nortriptyline—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000214	0.00233	CcSEcCtD
Nortriptyline—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000214	0.0182	CbGeAlD
Nortriptyline—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00232	CcSEcCtD
Nortriptyline—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.00232	CcSEcCtD
Nortriptyline—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000213	0.00232	CcSEcCtD
Nortriptyline—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000211	0.018	CbGeAlD
Nortriptyline—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.0023	CcSEcCtD
Nortriptyline—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00228	CcSEcCtD
Nortriptyline—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00227	CcSEcCtD
Nortriptyline—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000208	0.00227	CcSEcCtD
Nortriptyline—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00226	CcSEcCtD
Nortriptyline—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00226	CcSEcCtD
Nortriptyline—Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.000206	0.0554	CrCbGaD
Nortriptyline—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000205	0.00223	CcSEcCtD
Nortriptyline—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00223	CcSEcCtD
Nortriptyline—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00223	CcSEcCtD
Nortriptyline—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00222	CcSEcCtD
Nortriptyline—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00222	CcSEcCtD
Nortriptyline—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000204	0.00222	CcSEcCtD
Nortriptyline—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000204	0.00222	CcSEcCtD
Nortriptyline—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00222	CcSEcCtD
Nortriptyline—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000202	0.00221	CcSEcCtD
Nortriptyline—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.00221	CcSEcCtD
Nortriptyline—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00219	CcSEcCtD
Nortriptyline—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00218	CcSEcCtD
Nortriptyline—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00218	CcSEcCtD
Nortriptyline—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00218	CcSEcCtD
Nortriptyline—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00218	CcSEcCtD
Nortriptyline—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00214	CcSEcCtD
Nortriptyline—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00214	CcSEcCtD
Nortriptyline—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00214	CcSEcCtD
Nortriptyline—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000195	0.0166	CbGeAlD
Nortriptyline—HRH1—trachea—chronic obstructive pulmonary disease	0.000194	0.0165	CbGeAlD
Nortriptyline—SLC6A2—lung—chronic obstructive pulmonary disease	0.000193	0.0165	CbGeAlD
Nortriptyline—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000193	0.00211	CcSEcCtD
Nortriptyline—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.0021	CcSEcCtD
Nortriptyline—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000193	0.0164	CbGeAlD
Nortriptyline—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000192	0.0021	CcSEcCtD
Nortriptyline—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000192	0.0021	CcSEcCtD
Nortriptyline—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00209	CcSEcCtD
Nortriptyline—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00209	CcSEcCtD
Nortriptyline—Cyclobenzaprine—CYP1A2—chronic obstructive pulmonary disease	0.000192	0.0514	CrCbGaD
Nortriptyline—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00208	CcSEcCtD
Nortriptyline—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00019	0.00207	CcSEcCtD
Nortriptyline—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00206	CcSEcCtD
Nortriptyline—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00205	CcSEcCtD
Nortriptyline—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00202	CcSEcCtD
Nortriptyline—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000184	0.002	CcSEcCtD
Nortriptyline—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.002	CcSEcCtD
Nortriptyline—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000183	0.00199	CcSEcCtD
Nortriptyline—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00199	CcSEcCtD
Nortriptyline—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00199	CcSEcCtD
Nortriptyline—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00197	CcSEcCtD
Nortriptyline—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000179	0.00195	CcSEcCtD
Nortriptyline—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00195	CcSEcCtD
Nortriptyline—PTGS1—trachea—chronic obstructive pulmonary disease	0.000179	0.0153	CbGeAlD
Nortriptyline—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000178	0.00194	CcSEcCtD
Nortriptyline—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.00194	CcSEcCtD
Nortriptyline—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00193	CcSEcCtD
Nortriptyline—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000177	0.00192	CcSEcCtD
Nortriptyline—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000176	0.015	CbGeAlD
Nortriptyline—DRD2—lung—chronic obstructive pulmonary disease	0.000176	0.015	CbGeAlD
Nortriptyline—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00192	CcSEcCtD
Nortriptyline—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.0019	CcSEcCtD
Nortriptyline—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000175	0.0019	CcSEcCtD
Nortriptyline—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000174	0.0019	CcSEcCtD
Nortriptyline—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00189	CcSEcCtD
Nortriptyline—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00188	CcSEcCtD
Nortriptyline—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00188	CcSEcCtD
Nortriptyline—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000173	0.00188	CcSEcCtD
Nortriptyline—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000172	0.00188	CcSEcCtD
Nortriptyline—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000171	0.00186	CcSEcCtD
Nortriptyline—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000171	0.00186	CcSEcCtD
Nortriptyline—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00185	CcSEcCtD
Nortriptyline—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00185	CcSEcCtD
Nortriptyline—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00184	CcSEcCtD
Nortriptyline—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00184	CcSEcCtD
Nortriptyline—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00183	CcSEcCtD
Nortriptyline—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00183	CcSEcCtD
Nortriptyline—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00183	CcSEcCtD
Nortriptyline—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00181	CcSEcCtD
Nortriptyline—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00181	CcSEcCtD
Nortriptyline—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.0018	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.00179	CcSEcCtD
Nortriptyline—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.00179	CcSEcCtD
Nortriptyline—Maprotiline—CYP1A2—chronic obstructive pulmonary disease	0.000164	0.0439	CrCbGaD
Nortriptyline—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Nortriptyline—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Nortriptyline—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Nortriptyline—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.00177	CcSEcCtD
Nortriptyline—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.00177	CcSEcCtD
Nortriptyline—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00176	CcSEcCtD
Nortriptyline—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00176	CcSEcCtD
Nortriptyline—Cyclobenzaprine—HTR2A—chronic obstructive pulmonary disease	0.000162	0.0434	CrCbGaD
Nortriptyline—HTR2A—trachea—chronic obstructive pulmonary disease	0.000162	0.0138	CbGeAlD
Nortriptyline—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.00176	CcSEcCtD
Nortriptyline—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00176	CcSEcCtD
Nortriptyline—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000161	0.00175	CcSEcCtD
Nortriptyline—Epinastine—HTR2A—chronic obstructive pulmonary disease	0.000161	0.0431	CrCbGaD
Nortriptyline—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00174	CcSEcCtD
Nortriptyline—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00173	CcSEcCtD
Nortriptyline—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.0017	CcSEcCtD
Nortriptyline—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000156	0.0017	CcSEcCtD
Nortriptyline—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00169	CcSEcCtD
Nortriptyline—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00169	CcSEcCtD
Nortriptyline—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00169	CcSEcCtD
Nortriptyline—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00169	CcSEcCtD
Nortriptyline—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.00169	CcSEcCtD
Nortriptyline—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00167	CcSEcCtD
Nortriptyline—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000153	0.00167	CcSEcCtD
Nortriptyline—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000153	0.00167	CcSEcCtD
Nortriptyline—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000153	0.00167	CcSEcCtD
Nortriptyline—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000153	0.00167	CcSEcCtD
Nortriptyline—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00167	CcSEcCtD
Nortriptyline—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.00166	CcSEcCtD
Nortriptyline—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00166	CcSEcCtD
Nortriptyline—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00166	CcSEcCtD
Nortriptyline—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00164	CcSEcCtD
Nortriptyline—CYP1A2—lung—chronic obstructive pulmonary disease	0.000149	0.0126	CbGeAlD
Nortriptyline—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00161	CcSEcCtD
Nortriptyline—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.0016	CcSEcCtD
Nortriptyline—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.0016	CcSEcCtD
Nortriptyline—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.00158	CcSEcCtD
Nortriptyline—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000145	0.00158	CcSEcCtD
Nortriptyline—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000145	0.00158	CcSEcCtD
Nortriptyline—CYP3A5—lung—chronic obstructive pulmonary disease	0.000143	0.0122	CbGeAlD
Nortriptyline—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00154	CcSEcCtD
Nortriptyline—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00154	CcSEcCtD
Nortriptyline—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00154	CcSEcCtD
Nortriptyline—HRH1—lung—chronic obstructive pulmonary disease	0.000139	0.0118	CbGeAlD
Nortriptyline—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00151	CcSEcCtD
Nortriptyline—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00151	CcSEcCtD
Nortriptyline—Maprotiline—HTR2A—chronic obstructive pulmonary disease	0.000138	0.0371	CrCbGaD
Nortriptyline—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000138	0.0015	CcSEcCtD
Nortriptyline—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00149	CcSEcCtD
Nortriptyline—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00148	CcSEcCtD
Nortriptyline—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00146	CcSEcCtD
Nortriptyline—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00146	CcSEcCtD
Nortriptyline—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.00146	CcSEcCtD
Nortriptyline—CYP2E1—lung—chronic obstructive pulmonary disease	0.000134	0.0114	CbGeAlD
Nortriptyline—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00145	CcSEcCtD
Nortriptyline—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00144	CcSEcCtD
Nortriptyline—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00143	CcSEcCtD
Nortriptyline—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00143	CcSEcCtD
Nortriptyline—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00013	0.00142	CcSEcCtD
Nortriptyline—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.00142	CcSEcCtD
Nortriptyline—PTGS1—lung—chronic obstructive pulmonary disease	0.000129	0.011	CbGeAlD
Nortriptyline—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00139	CcSEcCtD
Nortriptyline—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00138	CcSEcCtD
Nortriptyline—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00136	CcSEcCtD
Nortriptyline—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00136	CcSEcCtD
Nortriptyline—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00136	CcSEcCtD
Nortriptyline—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00135	CcSEcCtD
Nortriptyline—Rash—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00135	CcSEcCtD
Nortriptyline—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00135	CcSEcCtD
Nortriptyline—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00135	CcSEcCtD
Nortriptyline—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00135	CcSEcCtD
Nortriptyline—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	0.000124	0.0332	CrCbGaD
Nortriptyline—Headache—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00134	CcSEcCtD
Nortriptyline—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00134	CcSEcCtD
Nortriptyline—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00134	CcSEcCtD
Nortriptyline—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00134	CcSEcCtD
Nortriptyline—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00134	CcSEcCtD
Nortriptyline—Cyproheptadine—HTR2A—chronic obstructive pulmonary disease	0.000123	0.0329	CrCbGaD
Nortriptyline—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00133	CcSEcCtD
Nortriptyline—Rash—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00132	CcSEcCtD
Nortriptyline—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00132	CcSEcCtD
Nortriptyline—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00132	CcSEcCtD
Nortriptyline—Mianserin—SLC6A4—chronic obstructive pulmonary disease	0.000121	0.0324	CrCbGaD
Nortriptyline—Headache—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00131	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000119	0.0013	CcSEcCtD
Nortriptyline—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00129	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00129	CcSEcCtD
Nortriptyline—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00128	CcSEcCtD
Nortriptyline—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00128	CcSEcCtD
Nortriptyline—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00127	CcSEcCtD
Nortriptyline—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00127	CcSEcCtD
Nortriptyline—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00127	CcSEcCtD
Nortriptyline—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000117	0.00127	CcSEcCtD
Nortriptyline—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.00127	CcSEcCtD
Nortriptyline—HTR2A—lung—chronic obstructive pulmonary disease	0.000116	0.00989	CbGeAlD
Nortriptyline—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00127	CcSEcCtD
Nortriptyline—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00125	CcSEcCtD
Nortriptyline—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000114	0.00125	CcSEcCtD
Nortriptyline—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00123	CcSEcCtD
Nortriptyline—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00123	CcSEcCtD
Nortriptyline—Clomipramine—SLC6A4—chronic obstructive pulmonary disease	0.000111	0.0297	CrCbGaD
Nortriptyline—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.0012	CcSEcCtD
Nortriptyline—Mianserin—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.0295	CrCbGaD
Nortriptyline—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.00119	CcSEcCtD
Nortriptyline—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00118	CcSEcCtD
Nortriptyline—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.00116	CcSEcCtD
Nortriptyline—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00114	CcSEcCtD
Nortriptyline—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.00113	CcSEcCtD
Nortriptyline—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00112	CcSEcCtD
Nortriptyline—Trimipramine—SLC6A4—chronic obstructive pulmonary disease	0.000102	0.0273	CrCbGaD
Nortriptyline—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00111	CcSEcCtD
Nortriptyline—Oxcarbazepine—ALB—chronic obstructive pulmonary disease	0.000101	0.0272	CrCbGaD
Nortriptyline—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000101	0.0011	CcSEcCtD
Nortriptyline—Clomipramine—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.027	CrCbGaD
Nortriptyline—Desipramine—ADRB2—chronic obstructive pulmonary disease	9.8e-05	0.0263	CrCbGaD
Nortriptyline—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.00106	CcSEcCtD
Nortriptyline—Doxepin—SLC6A4—chronic obstructive pulmonary disease	9.69e-05	0.026	CrCbGaD
Nortriptyline—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.62e-05	0.00105	CcSEcCtD
Nortriptyline—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.61e-05	0.00105	CcSEcCtD
Nortriptyline—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.55e-05	0.00104	CcSEcCtD
Nortriptyline—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	9.5e-05	0.0255	CrCbGaD
Nortriptyline—Mianserin—HTR2A—chronic obstructive pulmonary disease	9.29e-05	0.0249	CrCbGaD
Nortriptyline—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000972	CcSEcCtD
Nortriptyline—Desipramine—SLC6A4—chronic obstructive pulmonary disease	8.89e-05	0.0239	CrCbGaD
Nortriptyline—Doxepin—CYP1A2—chronic obstructive pulmonary disease	8.83e-05	0.0237	CrCbGaD
Nortriptyline—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.000957	CcSEcCtD
Nortriptyline—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.76e-05	0.000955	CcSEcCtD
Nortriptyline—Agitation—Prednisone—chronic obstructive pulmonary disease	8.7e-05	0.000948	CcSEcCtD
Nortriptyline—Malaise—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.000931	CcSEcCtD
Nortriptyline—Clomipramine—HTR2A—chronic obstructive pulmonary disease	8.5e-05	0.0228	CrCbGaD
Nortriptyline—Syncope—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000925	CcSEcCtD
Nortriptyline—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	8.46e-05	0.0227	CrCbGaD
Nortriptyline—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.45e-05	0.000921	CcSEcCtD
Nortriptyline—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000907	CcSEcCtD
Nortriptyline—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.2e-05	0.000894	CcSEcCtD
Nortriptyline—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.000891	CcSEcCtD
Nortriptyline—Desipramine—CYP1A2—chronic obstructive pulmonary disease	8.1e-05	0.0217	CrCbGaD
Nortriptyline—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.000875	CcSEcCtD
Nortriptyline—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.97e-05	0.000868	CcSEcCtD
Nortriptyline—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.84e-05	0.000854	CcSEcCtD
Nortriptyline—Trimipramine—HTR2A—chronic obstructive pulmonary disease	7.82e-05	0.021	CrCbGaD
Nortriptyline—Oedema—Prednisone—chronic obstructive pulmonary disease	7.73e-05	0.000842	CcSEcCtD
Nortriptyline—Shock—Prednisone—chronic obstructive pulmonary disease	7.6e-05	0.000829	CcSEcCtD
Nortriptyline—Imipramine—SLC6A4—chronic obstructive pulmonary disease	7.54e-05	0.0202	CrCbGaD
Nortriptyline—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.54e-05	0.000822	CcSEcCtD
Nortriptyline—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	7.5e-05	0.0201	CrCbGaD
Nortriptyline—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.47e-05	0.000814	CcSEcCtD
Nortriptyline—Doxepin—HTR2A—chronic obstructive pulmonary disease	7.45e-05	0.02	CrCbGaD
Nortriptyline—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.000803	CcSEcCtD
Nortriptyline—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.03e-05	0.000766	CcSEcCtD
Nortriptyline—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.99e-05	0.000762	CcSEcCtD
Nortriptyline—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.94e-05	0.000756	CcSEcCtD
Nortriptyline—Imipramine—CYP1A2—chronic obstructive pulmonary disease	6.87e-05	0.0184	CrCbGaD
Nortriptyline—Desipramine—HTR2A—chronic obstructive pulmonary disease	6.84e-05	0.0183	CrCbGaD
Nortriptyline—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	6.83e-05	0.0183	CrCbGaD
Nortriptyline—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.8e-05	0.000741	CcSEcCtD
Nortriptyline—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000732	CcSEcCtD
Nortriptyline—Rash—Prednisolone—chronic obstructive pulmonary disease	6.71e-05	0.000731	CcSEcCtD
Nortriptyline—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.7e-05	0.00073	CcSEcCtD
Nortriptyline—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.000726	CcSEcCtD
Nortriptyline—Headache—Prednisolone—chronic obstructive pulmonary disease	6.66e-05	0.000726	CcSEcCtD
Nortriptyline—Constipation—Prednisone—chronic obstructive pulmonary disease	6.61e-05	0.00072	CcSEcCtD
Nortriptyline—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000694	CcSEcCtD
Nortriptyline—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.32e-05	0.000688	CcSEcCtD
Nortriptyline—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.14e-05	0.000669	CcSEcCtD
Nortriptyline—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.11e-05	0.000666	CcSEcCtD
Nortriptyline—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.11e-05	0.000666	CcSEcCtD
Nortriptyline—Clomipramine—ALB—chronic obstructive pulmonary disease	5.81e-05	0.0156	CrCbGaD
Nortriptyline—Imipramine—HTR2A—chronic obstructive pulmonary disease	5.8e-05	0.0156	CrCbGaD
Nortriptyline—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	5.76e-05	0.0155	CrCbGaD
Nortriptyline—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.69e-05	0.00062	CcSEcCtD
Nortriptyline—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.55e-05	0.000604	CcSEcCtD
Nortriptyline—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.47e-05	0.000596	CcSEcCtD
Nortriptyline—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.29e-05	0.000576	CcSEcCtD
Nortriptyline—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.11e-05	0.000557	CcSEcCtD
Nortriptyline—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.000535	CcSEcCtD
Nortriptyline—Rash—Prednisone—chronic obstructive pulmonary disease	4.87e-05	0.000531	CcSEcCtD
Nortriptyline—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.87e-05	0.000531	CcSEcCtD
Nortriptyline—Headache—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000528	CcSEcCtD
Nortriptyline—Nausea—Prednisone—chronic obstructive pulmonary disease	4.59e-05	0.0005	CcSEcCtD
Nortriptyline—Amitriptyline—ALB—chronic obstructive pulmonary disease	3.94e-05	0.0106	CrCbGaD
Nortriptyline—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	5.5e-06	9.5e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.5e-06	9.49e-05	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.49e-06	9.47e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.48e-06	9.46e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.47e-06	9.44e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.47e-06	9.44e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.47e-06	9.44e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	5.46e-06	9.42e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.44e-06	9.4e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.43e-06	9.37e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.35e-06	9.23e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.28e-06	9.12e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.24e-06	9.04e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.22e-06	9.01e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.22e-06	9.01e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.19e-06	8.97e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.19e-06	8.96e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.18e-06	8.95e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.17e-06	8.92e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.16e-06	8.9e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	5.16e-06	8.9e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.12e-06	8.84e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.12e-06	8.84e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.11e-06	8.82e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.07e-06	8.76e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.07e-06	8.75e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.06e-06	8.74e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.05e-06	8.72e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.05e-06	8.71e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.04e-06	8.7e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.03e-06	8.68e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.03e-06	8.68e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.03e-06	8.68e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.01e-06	8.66e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5e-06	8.63e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5e-06	8.63e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.98e-06	8.6e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.98e-06	8.6e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.97e-06	8.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.97e-06	8.58e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.95e-06	8.54e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.94e-06	8.52e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.93e-06	8.51e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.92e-06	8.5e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.84e-06	8.36e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.82e-06	8.33e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.81e-06	8.3e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.77e-06	8.24e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.76e-06	8.22e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.76e-06	8.22e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.75e-06	8.2e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	4.73e-06	8.17e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	4.72e-06	8.15e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.71e-06	8.13e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.7e-06	8.12e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.69e-06	8.09e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.66e-06	8.05e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.6e-06	7.94e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.58e-06	7.91e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.53e-06	7.83e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.52e-06	7.8e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.51e-06	7.79e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.5e-06	7.77e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.49e-06	7.75e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.49e-06	7.74e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.47e-06	7.72e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.46e-06	7.7e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.46e-06	7.69e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.43e-06	7.65e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.42e-06	7.63e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.42e-06	7.62e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.29e-06	7.41e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.27e-06	7.37e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.24e-06	7.32e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.23e-06	7.31e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.23e-06	7.3e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.23e-06	7.29e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.2e-06	7.26e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.19e-06	7.24e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	4.19e-06	7.23e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.17e-06	7.2e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.13e-06	7.14e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.1e-06	7.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.09e-06	7.06e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.08e-06	7.04e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.03e-06	6.95e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	4.01e-06	6.92e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.01e-06	6.92e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4e-06	6.9e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.99e-06	6.89e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.98e-06	6.87e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.94e-06	6.81e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.91e-06	6.75e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.9e-06	6.74e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	3.9e-06	6.73e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.89e-06	6.72e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.89e-06	6.71e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.85e-06	6.65e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.83e-06	6.61e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.81e-06	6.57e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.78e-06	6.53e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.77e-06	6.51e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.72e-06	6.43e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.71e-06	6.4e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.7e-06	6.39e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.69e-06	6.37e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.68e-06	6.36e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.68e-06	6.35e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.65e-06	6.31e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.64e-06	6.29e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.63e-06	6.27e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.6e-06	6.22e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.6e-06	6.21e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.6e-06	6.21e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.59e-06	6.2e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.58e-06	6.19e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.54e-06	6.11e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.53e-06	6.1e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.53e-06	6.1e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	3.53e-06	6.09e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	3.52e-06	6.08e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.52e-06	6.08e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.51e-06	6.06e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.49e-06	6.03e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.47e-06	6e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.47e-06	5.99e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.47e-06	5.98e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.45e-06	5.96e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.44e-06	5.94e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.43e-06	5.93e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.43e-06	5.91e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.38e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.38e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.37e-06	5.82e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	3.37e-06	5.82e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.36e-06	5.8e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.35e-06	5.78e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.32e-06	5.73e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.31e-06	5.72e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.31e-06	5.71e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.3e-06	5.7e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.3e-06	5.7e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.3e-06	5.69e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.29e-06	5.68e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.28e-06	5.67e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.23e-06	5.58e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.23e-06	5.58e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.16e-06	5.45e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.14e-06	5.42e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.14e-06	5.42e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.12e-06	5.39e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.12e-06	5.39e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.09e-06	5.34e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.05e-06	5.26e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3e-06	5.17e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.99e-06	5.16e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.99e-06	5.16e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.98e-06	5.15e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.97e-06	5.13e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.97e-06	5.12e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.94e-06	5.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.93e-06	5.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.91e-06	5.02e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	2.9e-06	5.01e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.9e-06	5e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.88e-06	4.97e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.85e-06	4.92e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.84e-06	4.91e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.83e-06	4.89e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.83e-06	4.88e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.82e-06	4.86e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.8e-06	4.84e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.8e-06	4.83e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.79e-06	4.82e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.76e-06	4.77e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.75e-06	4.76e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.73e-06	4.71e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	2.72e-06	4.7e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.71e-06	4.68e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.71e-06	4.68e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.7e-06	4.67e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.7e-06	4.66e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.69e-06	4.64e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.68e-06	4.63e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.66e-06	4.6e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.65e-06	4.58e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.63e-06	4.55e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	2.6e-06	4.5e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.6e-06	4.49e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.59e-06	4.46e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.57e-06	4.44e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.54e-06	4.39e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.54e-06	4.38e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.52e-06	4.36e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.5e-06	4.32e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.48e-06	4.29e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.48e-06	4.29e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.47e-06	4.27e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.46e-06	4.25e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.44e-06	4.22e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.43e-06	4.2e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.43e-06	4.19e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.42e-06	4.18e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.41e-06	4.17e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.41e-06	4.17e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.41e-06	4.16e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.4e-06	4.14e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.39e-06	4.13e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.38e-06	4.12e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.38e-06	4.11e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.37e-06	4.1e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.27e-06	3.92e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.24e-06	3.86e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.23e-06	3.86e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.23e-06	3.85e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.23e-06	3.84e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.22e-06	3.84e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.22e-06	3.82e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.19e-06	3.79e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.19e-06	3.78e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.19e-06	3.78e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.19e-06	3.77e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.18e-06	3.76e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.17e-06	3.75e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.15e-06	3.71e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.14e-06	3.7e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.13e-06	3.68e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.12e-06	3.66e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.12e-06	3.66e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.03e-06	3.5e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.03e-06	3.5e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.95e-06	3.36e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.94e-06	3.35e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.87e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.86e-06	3.2e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.84e-06	3.18e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.84e-06	3.17e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.83e-06	3.16e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.82e-06	3.15e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.81e-06	3.12e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.8e-06	3.11e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.71e-06	2.95e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.68e-06	2.91e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.68e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.67e-06	2.89e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.67e-06	2.88e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.65e-06	2.85e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.65e-06	2.85e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.64e-06	2.83e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.57e-06	2.7e-05	CbGpPWpGaD
